On Thursday, August 16th, the FDA released a list of medical device accessories that have the potential to be reclassified as class I devices.
According to section 513 of the Food, Drug, & Cosmetic (FD&C) Act, medical devices are organized into three categories. Device classification depends on intended use and is based on the amount of risk associated with the device, and therefore, the level of regulatory control necessary to provide reasonable assurance of its safety and effectiveness. The three classes include:
The regulatory requirements vary based on the devices classification. As device class increases from Class I to Class III, the associated risk and thus the regulatory controls also increase; Class I devices have the least amount of risk and thus the are subject to the least regulatory control, and Class III are the highest risk and have the most rigorous regulatory control.
However, the classification, and therefore level of regulation, may be changing for some aspects of some medical devices. Late last week, the FDA announced that certain Class II and III medical devices may have accessories suitable for reclassification into class I if they are considered separately from the parent device.
According to the recent Federal Register notice, “the classification of each accessory will be based on the risks of the accessory when used as intended and the level of regulatory controls necessary to provide a reasonable assurance of safety and effectiveness of the accessory, notwithstanding the classification of any other device with which such accessory is intended to be used.”
A medical device accessory is considered eligible for a reclassification if:
FDA believes that reclassifying certain medical device accessories into Class I will reduce regulatory burden and allow the Agency to focus on other products that post a greater risk.
A full list of proposed accessories for reclassification can be found in the recent notice. FDA is seeking public comment on the recently publication list until Tuesday, October 16, 2018.
February 28, 2019
On Tuesday, February 19th, FDA published a draft guidance for medical device makers which identifies a process for companies to request nonbinding feedback on certain FDA Form 483 deficiencies noted...
February 11, 2016
On February 9, 2016, the FDA published a draft guidance entitled “Display Devices for Diagnostic Radiology.” The document, which will replace a 2008 guidance (“Display Accessories for Full-Field...
August 31, 2015
Earlier this year, FDA published a report announcing that the Agency’s device program has shown “a pattern of markedly improved performance.” Over the past five years, FDA has been working to improve...